ENFINIT PLATFORM FOR CAR-T
LIVE

Serial Number

79330693

Owner

MNEMO THERAPEUTICS

Attorney

Jill Anderfuren

Filing Date

Sep 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ENFINIT PLATFORM FOR CAR-T Trademark

Serial Number: 79330693

ENFINIT PLATFORM FOR CAR-T is a trademark filed by MNEMO THERAPEUTICS on September 14, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

MNEMO THERAPEUTICS (4 trademarks)

7-11 boulevard Haussmann

Entity Type: 34

Trademark Details

Filing Date

September 14, 2021

Registration Date

Not Registered

Goods & Services

Biological and chemical preparations for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions

Pharmaceutical products for use in the fields of oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; pharmaceutical antigens, antibodies, and cells for therapeutic use

Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacturing of antigens, antibodies, T-cells; Providing medical information relating to immunotherapy; information, advice and consulting services related to the field of pharmaceutical products manufacturing

Scientific research services, namely medical research; scientific research and product development, namely, identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information on immunotherapy; providing scientific research services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific analysis, namely, epigenetic antigen screening and identification services for therapeutic research purposes; scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses

Providing medical information relating to immunotherapy

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 24, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 24, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 23, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 18, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 17, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 16, 2024 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 17, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 31, 2024 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 9, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 12, 2023 RCSC
ATTORNEY REVIEW COMPLETED
Apr 11, 2023 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Apr 11, 2023 CREV
USPTO CORRECTION PROCESSED BY IB
Mar 5, 2023 RINX
USPTO CORRECTION PROCESSED BY IB
Mar 5, 2023 RINX
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 5, 2023 CRCV
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 9, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 9, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 9, 2023 CNSL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 6, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2023 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 5, 2023 TROA
CORRECTION SENT TO IB
Dec 12, 2022 CRSN
CORRECTION SENT TO IB
Dec 12, 2022 CRSN
CORRECTION CREATED FOR IB
Dec 7, 2022 CRCR
CORRECTION CREATED FOR IB
Dec 7, 2022 CRCR
REFUSAL PROCESSED BY IB
Jul 26, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 11, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 6, 2022 REPR